Ohmori; Osamu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ohmori; Osamu.The latest application filed is for "2,4- diaminopyrimidine derivatives".

Company Profile

0.17.17

Ohmori; Osamu - Kariya N/A JP
Ohmori; Osamu - Izunokuni JP
OHMORI; Osamu - Tsukuba-shi JP
Ohmori; Osamu - Kariya-shi JP
Ohmori; Osamu - Tsukuba N/A JP
Ohmori; Osamu - Shizuoka N/A JP
Ohmori; Osamu - Ibaraki JP
Ohmori; Osamu - Izunokuni-shi JP
Ohmori; Osamu - Ibaraki Pref JP
Ohmori; Osamu - Kawasaki JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Condensed polycyclic aromatic compound, production process of same, and positive electrode active material for lithium ion secondary battery containing same Grant 8,927,157 - Ohmori , et al. January 6, 2	2015-01-06
Organic compounds Grant 8,759,365 - Mogi , et al. June 24, 2	2014-06-24
2,4- Diaminopyrimidine Derivatives App 20130345180 - BAENTELI; Rolf ; et al.	2013-12-26
Electrolytic Solution And Lithium-ion Secondary Battery App 20130330607 - Mizuno; Kayo ; et al.	2013-12-12
2,4-diaminopyrimidine derivatives Grant 8,431,589 - Baenteli , et al. April 30, 2	2013-04-30
Bicyclic derivatives as CETP inhibitors Grant 8,410,275 - Kishida , et al. April 2, 2	2013-04-02
Condensed Polycyclic Aromatic Compound, Production Process Of Same, And Positive Electrode Active Material For Lithium Ion Secondary Battery Containing Same App 20130078514 - Ohmori; Osamu ; et al.	2013-03-28
Pyrimidine derivatives Grant 8,263,590 - Garcia-Echeverria , et al. September 11, 2	2012-09-11
Bicyclic Derivatives As Cetp Inhibitors App 20120225874 - KISHIDA; Masashi ; et al.	2012-09-06
Bicyclic derivatives as CETP inhibitors Grant 8,232,403 - Kishida , et al. July 31, 2	2012-07-31
Pyrimidine Derivatives App 20110201606 - Garcia-Echeverria; Carlos ; et al.	2011-08-18
2,4- Diaminopyrimidine Derivatives App 20110172231 - BAENTELI; Rolf ; et al.	2011-07-14
2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders Grant 7,964,592 - Garcia-Echeverria , et al. June 21, 2	2011-06-21
2,4-diaminopyrimidine derivatives Grant 7,943,627 - Baenteli , et al. May 17, 2	2011-05-17
2,4-pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders App 20110098280 - Garcia-Echeverria; Carlos ; et al.	2011-04-28
2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders Grant 7,893,074 - Garcia-Echeverria , et al. February 22, 2	2011-02-22
Organic Compounds App 20100311750 - Mogi; Muneto ; et al.	2010-12-09
Polyurethanes, Polyureas, And Process For Their Production App 20100204356 - Yamamoto; Yusuke ; et al.	2010-08-12
Organic Compounds App 20090286790 - Imase; Hidetomo ; et al.	2009-11-19
Bicyclic derivatives as CETP inhibitors App 20090227580 - Kishida; Masashi ; et al.	2009-09-10
Pyrimidine Derivatives App 20090131436 - Imbach; Patricia ; et al.	2009-05-21
2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders App 20080132504 - Garcia-Echeverria; Carlos ; et al.	2008-06-05
2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders App 20060247241 - Garcia-Echeverria; Carlos ; et al.	2006-11-02
Pyrimidine derivaties App 20060100227 - Baenteli; Rolf ; et al.	2006-05-11
Library apparatus for disc cartridge Grant 6,449,223 - Kanetsuku , et al. September 10, 2	2002-09-10
Cartridge forced exit station for a library apparatus Grant 6,198,594 - Utsumi , et al. March 6, 2	2001-03-06
Cartridge entry/exit station for a library apparatus Grant 6,088,189 - Utsumi , et al. July 11, 2	2000-07-11
Cartridge direct entry/exit station for library apparatus Grant 5,940,243 - Kanetsuku , et al. August 17, 1	1999-08-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.